Current Alzheimer Research
Title: Editorial [Hot Topic: Advances in Alzheimer Therapy: Development of Innovative New Strategies (Guest Editors: Nigel H. Greig, Ezio Giacobini and Debomoy K. Lahiri)]
Volume: 4 Issue: 4
Author(s): Nigel H. Greig, Ezio Giacobini and Debomoy K. Lahiri
Affiliation:
Export Options
About this article
Cite this article as:
Greig H. Nigel, Giacobini Ezio and Lahiri K. Debomoy, Editorial [Hot Topic: Advances in Alzheimer Therapy: Development of Innovative New Strategies (Guest Editors: Nigel H. Greig, Ezio Giacobini and Debomoy K. Lahiri)], Current Alzheimer Research 2007; 4 (4) . https://dx.doi.org/10.2174/156720507781788819
DOI https://dx.doi.org/10.2174/156720507781788819 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective and Preventative Effects of Molecular Hydrogen
Current Pharmaceutical Design Heat Shock Proteins and Proteasome Function in Neurodegeneration
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Editorial (Thematic Issue: An Overwiew on the Chemistry and Biochemistry of Triterpenoids)
Mini-Reviews in Organic Chemistry Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides
Current Cancer Drug Targets The Antidepressant-like Effects of Estrogen-mediated Ghrelin
Current Neuropharmacology Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Current Drug Targets Nanotubes at Neural and Immune Synapses
Current Medicinal Chemistry PET Radiotracers for Molecular Imaging of Serotonin 5-HT<sub>1A</sub> Receptors
Current Medicinal Chemistry Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders
Combinatorial Chemistry & High Throughput Screening Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Current Alzheimer Research The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease
Current Pharmaceutical Design Gene Therapy for Peripheral Nervous System Diseases
Current Gene Therapy Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design Docosahexaenoic Acid-Containing Phospholipids and Triglycerides Based Nutritional Supplements
Recent Patents on Food, Nutrition & Agriculture Applications of Indan-1,3-Dione in Heterocyclic Synthesis
Current Organic Synthesis Editorial [ Therapeutics for Protein Misfolding Diseases Executive Editor: Claudio Soto ]
Current Pharmaceutical Design Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer's Disease After Implantation of VEGF-loaded PLGA Nanospheres
Current Alzheimer Research Nerve Growth Factor: A Focus on Neuroscience and Therapy
Current Neuropharmacology